This webinar will focus on how to support decision making through validated standardized assessment of metric properties and issues related to administration of PROs with the ‘Evaluating Measures of Patient Reported Outcomes’ (EMPRO) system.
The purposes of this webinar are to define each attribute assessed by this tool, and to explain how to apply them to generic and specific PROs. The scoring algorithm and its rationale will be described. Other complementary evaluative tools, such as the COSMIN checklist to appraise the methodological quality of metric properties’ studies, will be addressed. This webinar includes lessons for all researchers interested in valuation of metric properties.
Researchers and health professionals face the problem of selecting the most appropriate PRO tool for a given purpose among competing instruments.
EMPRO was developed to assess an instrument’s quality, considering all available information. It consists of standardized expert evaluations of 8 key measurement attributes for each PRO, resulting in scores that allow direct comparisons among instruments. These attributes were originally proposed by the Medical Outcomes Trust: Concept and measurement model; Reliability; Validity; Sensitivity to change; Interpretation; Burden; Alternative modes of administration; Cultural adaptation.
After the webinar, the learner will be able to recognize and apply the criteria required for the evaluation of the eight attributes assessed with EMPRO system:
- Sensitivity to change
- Alternative modes of administration
- Cultural adaptation.
- Jordi Alonso, MD PhD, Institut Hospital del Mar d’Investigacions Médiques, Health Services Research Group
- Montse Ferrer, MD MPH PhD, Institut Hospital del Mar d’Investigacions Médiques, Health Services Research Group
- Gemma Vilagut, MSc, Institut Hospital del Mar d’Investigacions Médiques, Health Services Research Group
- Olatz Garin, PhD, Institut Hospital del Mar d’Investigacions Médiques, Health Services Research Group
- Jose M. Valderas, MD MPH PhD, University of Exeter Medical School, PenCLAHRC, Institute of Health Services Research
Carlos Garcia Forero, PhD, Institut Hospital del Mar d’Investigacions Médiques, Health Services Research Group
The Ibero SIG